Souhaitez-vous accéder aux communiqués récents ?

Pressmeddelande 14 april 2021 Immunicum AB (publ) inleder forskningssamarbete med Icahn School of Medicine vid Mount Sinai Immunicum AB (publ; IMMU.ST) tillkännagav idag inledandet av ett...

Press Release 14 April 2021 Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai Immunicum AB (publ; IMMU.ST) announced today the initiation of a...

Pressmeddelande 12 april 2021 Immunicum AB (publ) offentliggör årsredovisning för 2020 Immunicum AB meddelar idag att årsredovisningen för 2020 nu finns tillgänglig på bolagets hemsida,...

Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the...

Pressrelease 7 april 2021 Immunicum bjuder in till investerarmöte och meddelar deltagande i konferenser i april Immunicum AB (publ) meddelar idag att bolaget kommer att deltaga i ett antal...

Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ) today announced its participation in multiple upcoming investor...

Press Release 31 March 2021 KALLELSE TILL ÅRSSTÄMMA I IMMUNICUM AB (PUBL) Aktieägarna i Immunicum AB (publ) (”Bolaget”), org.nr 556629-1786, kallas härmed till årsstämma tisdagen den 4 maj 2021...

Press Release 31 March 2021 NOTICE OF ANNUAL GENERAL MEETING IN IMMUNICUM AB (PUBL) The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Annual...

Pressmeddelande 16 mars 2021  Immunicum AB (publ) meddelar förändringar i ledningsgruppen efter sammanslagningen Immunicum AB (publ; IMMU.ST) meddelar idag förändringar i bolagets ledningsgrupp...

Press Release 16 March 2021  Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination Immunicum AB (publ; IMMU.ST) announced today the establishment of an updated...